Oral contraceptives & breast cancer:
Gespeichert in:
Körperschaft: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Washington, D.C.
National Academy Press
1991
|
Schlagworte: | |
Beschreibung: | Paralleltitel: Oral contraceptives and breast cancer Includes bibliographical references and index |
Beschreibung: | x, 185 p. |
ISBN: | 0309044936 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV044107285 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 170217s1991 |||| o||u| ||||||eng d | ||
020 | |a 0309044936 |9 0-309-04493-6 | ||
035 | |a (ZDB-30-PAD)EBC3376577 | ||
035 | |a (ZDB-89-EBL)EBL3376577 | ||
035 | |a (OCoLC)49853767 | ||
035 | |a (DE-599)BVBBV044107285 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
082 | 0 | |a 616.99/449071 |2 20 | |
110 | 2 | |a Institute of Medicine (U.S.) |b Committee on the Relationship Between Oral Contraceptives and Breast Cancer |e Verfasser |4 aut | |
245 | 1 | 0 | |a Oral contraceptives & breast cancer |c Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention |
246 | 1 | 3 | |a Oral contraceptives and breast cancer |
264 | 1 | |a Washington, D.C. |b National Academy Press |c 1991 | |
300 | |a x, 185 p. | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Paralleltitel: Oral contraceptives and breast cancer | ||
500 | |a Includes bibliographical references and index | ||
650 | 4 | |a Breast |x Cancer |x Epidemiology |v Congresses | |
650 | 4 | |a Oral contraceptives |x Side effects |v Congresses | |
650 | 0 | 7 | |a Ovulationshemmer |0 (DE-588)4044229-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
689 | 0 | 0 | |a Ovulationshemmer |0 (DE-588)4044229-9 |D s |
689 | 0 | 1 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
689 | 0 | 2 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
912 | |a ZDB-30-PAD | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-029514130 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk |
Datensatz im Suchindex
_version_ | 1804177172564279296 |
---|---|
any_adam_object | |
author_corporate | Institute of Medicine (U.S.) Committee on the Relationship Between Oral Contraceptives and Breast Cancer |
author_corporate_role | aut |
author_facet | Institute of Medicine (U.S.) Committee on the Relationship Between Oral Contraceptives and Breast Cancer |
author_sort | Institute of Medicine (U.S.) Committee on the Relationship Between Oral Contraceptives and Breast Cancer |
building | Verbundindex |
bvnumber | BV044107285 |
collection | ZDB-30-PAD |
ctrlnum | (ZDB-30-PAD)EBC3376577 (ZDB-89-EBL)EBL3376577 (OCoLC)49853767 (DE-599)BVBBV044107285 |
dewey-full | 616.99/449071 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.99/449071 |
dewey-search | 616.99/449071 |
dewey-sort | 3616.99 6449071 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01914nmm a2200457zc 4500</leader><controlfield tag="001">BV044107285</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s1991 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309044936</subfield><subfield code="9">0-309-04493-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC3376577</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL3376577</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)49853767</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044107285</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/449071</subfield><subfield code="2">20</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Committee on the Relationship Between Oral Contraceptives and Breast Cancer</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Oral contraceptives & breast cancer</subfield><subfield code="c">Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Oral contraceptives and breast cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academy Press</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">x, 185 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Paralleltitel: Oral contraceptives and breast cancer</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Epidemiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oral contraceptives</subfield><subfield code="x">Side effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ovulationshemmer</subfield><subfield code="0">(DE-588)4044229-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Ovulationshemmer</subfield><subfield code="0">(DE-588)4044229-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029514130</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
id | DE-604.BV044107285 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:43:51Z |
institution | BVB |
isbn | 0309044936 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029514130 |
oclc_num | 49853767 |
open_access_boolean | |
physical | x, 185 p. |
psigel | ZDB-30-PAD |
publishDate | 1991 |
publishDateSearch | 1991 |
publishDateSort | 1991 |
publisher | National Academy Press |
record_format | marc |
spelling | Institute of Medicine (U.S.) Committee on the Relationship Between Oral Contraceptives and Breast Cancer Verfasser aut Oral contraceptives & breast cancer Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention Oral contraceptives and breast cancer Washington, D.C. National Academy Press 1991 x, 185 p. txt rdacontent c rdamedia cr rdacarrier Paralleltitel: Oral contraceptives and breast cancer Includes bibliographical references and index Breast Cancer Epidemiology Congresses Oral contraceptives Side effects Congresses Ovulationshemmer (DE-588)4044229-9 gnd rswk-swf Brustkrebs (DE-588)4008528-4 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Ovulationshemmer (DE-588)4044229-9 s Brustkrebs (DE-588)4008528-4 s Arzneimittelnebenwirkung (DE-588)4003134-2 s 1\p DE-604 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Oral contraceptives & breast cancer Breast Cancer Epidemiology Congresses Oral contraceptives Side effects Congresses Ovulationshemmer (DE-588)4044229-9 gnd Brustkrebs (DE-588)4008528-4 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd |
subject_GND | (DE-588)4044229-9 (DE-588)4008528-4 (DE-588)4003134-2 (DE-588)1071861417 |
title | Oral contraceptives & breast cancer |
title_alt | Oral contraceptives and breast cancer |
title_auth | Oral contraceptives & breast cancer |
title_exact_search | Oral contraceptives & breast cancer |
title_full | Oral contraceptives & breast cancer Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention |
title_fullStr | Oral contraceptives & breast cancer Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention |
title_full_unstemmed | Oral contraceptives & breast cancer Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention |
title_short | Oral contraceptives & breast cancer |
title_sort | oral contraceptives breast cancer |
topic | Breast Cancer Epidemiology Congresses Oral contraceptives Side effects Congresses Ovulationshemmer (DE-588)4044229-9 gnd Brustkrebs (DE-588)4008528-4 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd |
topic_facet | Breast Cancer Epidemiology Congresses Oral contraceptives Side effects Congresses Ovulationshemmer Brustkrebs Arzneimittelnebenwirkung Konferenzschrift |
work_keys_str_mv | AT instituteofmedicineuscommitteeontherelationshipbetweenoralcontraceptivesandbreastcancer oralcontraceptivesbreastcancer AT instituteofmedicineuscommitteeontherelationshipbetweenoralcontraceptivesandbreastcancer oralcontraceptivesandbreastcancer |